Press releases

Innovative Lipid Imaging Tool to Be Presented at Biotech Israel 2005

May 24, 2005, Tel Aviv, Israel - QuantomiX Ltd. will present its high-resolution lipid imaging technology at Biotech Israel 2005 on May 24, accompanied by high expectations from industry leaders. This technology permits high resolution imaging, analysis, and quantification of lipid bodies in cells and tissues - a capability that can serve as an early indication for the onset of metabolic disorders. Recent research has shown that lipid imaging using QuantomiX WETSEM^TM technology may hold the key to drug evaluation for metabolic diseases.

Lipid imaging under high resolution has unveiled new insights on the precise morphology of lipids, a key component in understanding metabolic syndrome. The ability to view the process of fat accumulation in tissues and insulin resistance with WETSEM^TM, provide an early indication on the effectiveness of drugs in pre-clinical and clinical trials. With the importance of metabolic syndrome in the developed world, this ability is crucial for modern drug development.

Bio-Tech Israel 2005 - The Israel Biomedical Technologies Conference and Exhibition, scheduled to take place on May 24-26, 2005 in Tel Aviv, Israel, is an annual event which brings together the players in the biotech field worldwide. The 2005 conference will focus on four disease areas, one of which is metabolic disorders. "This focus has pushed QuantomiX to present its exciting technology at Biotech," explains Ory Zik, the company's CEO. "The QuantomiX technology is highly useful in metabolic syndrome research, and can become a stepping stone to better understanding of this range of disorders," he clarifies.

Barbara Corkey, Ph.D., Professor of Medicine and Biochemistry and Director of the Obesity Research Center at Boston Medical Center, Boston University, and head of the North American Organization for the Study of Obesity (NAASO), will be attending the Biotech conference. "QuantomiX technology promises to be an important aid in lipid accumulation research as part of the study of obesity," she declares.

QuantomiX technology, the only comprehensive solution for lipid imaging and quantification, is expected to open new vistas in drug development for metabolic syndrome and other hitherto unexplored avenues of research.

About QuantomiX

QuantomiX develops and markets breakthrough solutions based on its proprietary WETSEM^TM technology. QuantomiX innovative technology which allows high resolution imaging of wet samples, opens new opportunities for application-specific tools to improve drug discovery, and advances treatment and diagnostic solutions for the medical and pharmaceutical markets.